APA (7th ed.) Citation

S, S., & R, S. (2026). Do GPCRs constitute the target of 30% of newly approved drugs in Germany? Naunyn-Schmiedeberg's archives of pharmacology, 399(4), 5575. https://doi.org/10.1007/s00210-025-04548-3

Chicago Style (17th ed.) Citation

S, Schröer, and Seifert R. "Do GPCRs Constitute the Target of 30% of Newly Approved Drugs in Germany?" Naunyn-Schmiedeberg's Archives of Pharmacology 399, no. 4 (2026): 5575. https://doi.org/10.1007/s00210-025-04548-3.

MLA (9th ed.) Citation

S, Schröer, and Seifert R. "Do GPCRs Constitute the Target of 30% of Newly Approved Drugs in Germany?" Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 399, no. 4, 2026, p. 5575, https://doi.org/10.1007/s00210-025-04548-3.